Summary

Multidetector CT technology will likely replace conventional angiography and Digital Subtraction Angiography in the diagnosis and treatment of aneurysms. MDCT technology is safer and nearly as sensitive as DSA, and can be used reliably in making treatment decisions for intracranial aneurysms.

Analysis

This article will impact companies such as GE, Phillips, Siemens and others in the field of diagnostic radiology.  While current technology for CT angiography is limited, MDCT will likely produce images of such high quality and resolution, that Digital Subtraction Angiography will be replaced within 5 years by these new technologies.  This shift in paradigm may spill into the cardiovascular disease arena, where the market is significantly larger, and the demand for safer diagnostic vascular studies is higher.

This author consults with leading institutions through GLG

Engage this author or other Healthcare experts
 
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.